Psychiatry & Neurology Doctors in Owatonna, MN Accepting Medicare

4 Psychiatry & Neurology doctors found. Showing 1 - 4

Claudia Cuervo, MD Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 610 Florence Ave, Owatonna, MN 55060 Phone: 507-451-2630    Fax: 507-455-8133

Naila Goenka, MD Psychiatry & Neurology - Clinical Neurophysiology Medicare: Not Enrolled in Medicare Practice Location: 2200 Nw 26th St, Owatonna, MN 55060 Phone: 507-444-5044

Dr. David Ritland Tverberg, M.D. Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 610 Florence Ave, Owatonna, MN 55060 Phone: 507-451-2630    Fax: 507-455-8133

Joseph Richard Wilson, M.D. Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 610 Florence Ave, Owatonna, MN 55060 Phone: 507-451-2630

News Archive

AstraZeneca Canada's IRESSA receives approval for treatment of NSCLC

AstraZeneca Canada announces the recently approved indication for IRESSA(R), a once-daily oral targeted therapy for the first-line treatment of patients with locally advanced (not amenable to curative therapy) or metastatic non-small cell lung cancer (NSCLC) who have activating mutations of the epidermal growth factor receptor-tyrosine kinase (EGFR-TK). In conjunction with this approval, AstraZeneca is also announcing the availability of a diagnostic test which can now determine a patient's EGFR mutation status, representing a new era in personalized lung cancer treatment in Canada.

LifeVantage Corporation invites independent distributor applications in Mexico ahead of planned product launches

LifeVantage Corporation (OTCBB: LFVN), a science-based, natural products company dedicated to helping people reach their health and wellness goals through science-based solutions for oxidative stress and the maker of Protandim® and TrueScience™ Anti-Aging Cream, announced today that independent distributor applications and orders are being accepted in Mexico in anticipation of a launch late this summer.

Study reveals that daily bathroom showers may deliver pathogenic bacteria

While daily bathroom showers provide invigorating relief and a good cleansing for millions of Americans, they also can deliver a face full of potentially pathogenic bacteria, according to a surprising new University of Colorado at Boulder study.

Study could guide future treatment of multisystem inflammatory syndrome in children

Children and adolescents with multisystem inflammatory syndrome in children (MIS-C) who are treated initially with intravenous immune globulin (IVIG) and glucocorticoids have reduced risk for serious short-term outcomes, including cardiovascular dysfunction, than those who receive an initial treatment of IVIG alone, a new study finds.

Read more Medical News

› Verified 5 days ago